Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs (Q95625027)
Jump to navigation
Jump to search
scientific article published on 20 February 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs |
scientific article published on 20 February 2020 |
Statements
Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs (English)
Rimanshee Arya
Amit Das
Vishal Prashar
Mukesh Kumar
20 February 2020
Identifiers
1 reference